Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Development of gene expression signatures for human liver fibrosis

ABSTRACT: To further development of our gene expression approach to biodosimetry, we have employed whole genome microarray expression profiling as a discovery platform to to study the genes that change in the progress of human liver fibrosis, so as to provide a basis for the clinical treatment of liver fibrosis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE197112 | GEO | 2022/02/22

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene expression signatures for breast cancer cell lines

2022-02-23 | GSE159661 | GEO

MiR-29a regulates liver fibrosis

Project description:To confirm the mechanism of miR-29a in liver fibrosis healing, we have employed whole genome microarray expression profiling as a discovery platform to identify genes. CCl4 and TAA liver fibrosis model mouse were used for this experiment. After five weeks liver fibrosis induction period, mouse have been observed for one week (1w) or two weeks (2w) and negative control nucleotide (N.C) or miR-29a were injected every 3 days on this period. We used CCl4 1w N.C (n = 1), 1w miR-29a (n = 1), 2w N.C (n = 1), 2w miR-29a (n = 1), and also used TAA model mouse (total n = 8) liver samples for microarray analysis. We can get only one gene (PDGF-c) as a target of miR-29a which relate to liver fibrosis and down-regulated more than 1.5 times in common miR-29a injected group than N.C group. CCl4 and TAA liver fibrosis model mouse were used for this experiment. After five weeks liver fibrosis induction period, mouse have been obserbed for one week (1w) or two weeks (2w) and negative control nucleotide (N.C) or miR-29a were injected every 3 days on this period. We used CCl4 1w N.C (n = 1), 1w miR-29a (n = 1), 2w N.C (n = 1), 2w miR-29a (n = 1), and also used TAA model mouse (total n = 8) liver samples for microarray analysis.

2015-03-31 | E-GEOD-67423 | biostudies-arrayexpress

Development of gene expression signatures for knock down expression of ARL4C

Project description:o further development of our gene expression approach to biodosimetry, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the potential to distinguish expression of ARL4C. Human primay GBM cell was transfected with control or eGFP-Sh-ARL4C lentivirus, 588 gene are down-regulated and 366 gene are down-regulated.

2019-06-04 | GSE121253 | GEO

MiR-29a regulates liver fibrosis

2015-03-31 | GSE67423 | GEO

Development of gene expression signatures for knock down expression of semaphorin 3F

Project description:To further development of our gene expression approach to biodosimetry, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the potential to distinguish expression of semaphorin3F. Human colorectal cancer cell HCT116 was infected with empty control or eGFP-Sh-SEMA3F lentivirus,1468 genes was found altered significantly,709 genes was upregulated and 759 genes was downregulated significantly

2014-09-16 | GSE61419 | GEO

Development of gene expression signatures for knock down expression of semaphorin 3F

Project description:To further development of our gene expression approach to biodosimetry, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the potential to distinguish expression of semaphorin3F. Human colorectal cancer cell HCT116 was infected with empty control or eGFP-Sh-SEMA3F lentivirus,1468 genes was found altered significantly,709 genes was upregulated and 759 genes was downregulated significantly knock down expression of semaphorin3F induced gene expression in human colorectal cancer cell was measured. Three independent experiments were performed for each experiment

2014-09-16 | E-GEOD-61419 | biostudies-arrayexpress

Gene expression of Wild Type and SR-A1-/- abdominal aortic tissues after CaPO4-envoked

2023-05-28 | GSE226304 | GEO

Development of gene expression signatures of liver in a primary Sjögren's syndrome mouse model

Project description:To elucidate gene expression signatures of liver induced by Sjögren's syndrome, we have employed whole genome microarray expression profiling as a discovery platform.

2023-12-11 | GSE249144 | GEO

Development of gene expression signatures for practical radiation biodosimetry

Project description:To further development of our gene expression approach to biodosimetry, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the potential to distinguish radiation dose across an exposure range relevant for medical decision-making in a radiological emergency. Human peripheral blood from healthy donors was irradiated ex vivo, and a 74-gene consensus signature was identified that distinguished between four radiation doses (0.5, 2, 5 and 8 Gy) and control samples. The same set of genes separated samples by exposure level at both six and 24 hours after treatment, with overlap evident only at the highest two doses (5 and 8 Gy). Expression of five genes (CDKN1A, FDXR, SESN1, BBC3 and PHPT1) from this signature was quantified in the same RNA samples by real-time PCR, confirming low variability between donors as well as the predicted radiation response pattern. Keywords: Dose Response, stress response, radiation response, biodosimetry

2008-07-01 | GSE8917 | GEO

Development of gene expression signatures for high glucose-induced renal tubular fibrosis

Project description:To further explore differentially expressed genes in high glucose-induced renal tubular fibrosis cells, we used whole transcriptome microarray expression profiling as a discovery platform to identify genes with a potential role in the high glucose-induced renal fibrosis process. Low-glucose stimulation (5.5 mM glucose) and high-glucose stimulation (25 mM glucose) of human renal tubular HK2 cells identified a consensus profile of 644 highly expressed genes to distinguish high-glucose fibrotic renal tubules from control samples.

2024-06-30 | GSE232913 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data